PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 10, 2026Lab on a Chip0 citationsOpen Access

Band-stop microfluidics for high-purity, label-free enrichment of viable cancer cells from whole blood

LKLewis KrzeczkowskiLondon CancerGNGeorgios NteliopoulosLondon CancerSASimak Ali

Key Points

  • The aim is to develop a microfluidic method for isolating viable cancer cells from whole blood with high purity.
  • Introduced a microfluidic band-stop filter for size-selective cell capture.
  • Utilized hydrodynamic filtering coupled with hydrodynamic trapping.
  • Tested the device with rigid microspheres and cultured cancer cell lines.
  • Evaluated performance in undiluted whole blood for leukocyte contamination.
  • Captured cancer cells within a specific size range with high efficiency.
  • No retention of leukocytes was observed in whole blood samples.
  • Demonstrated cell viability post-capture and response to drug exposure.
  • Performance metrics matched those of commercial systems.

Abstract

Liquid biopsy requires the isolation of viable circulating tumour cells (CTCs) from whole blood at high purity and with sufficient quality for functional assays. These requirements are not readily met by either label-based methods or size-only low-pass filters. Antibody labels can be specific yet miss phenotypically diverse CTCs, while size-based approaches may capture more broadly but suffer from leukocyte contamination. Here, we introduce a microfluidic band-stop filter that implements a size-selective transfer function, replacing a single threshold with an engineered peaked size-capture response. This is achieved by coupling hydrodynamic filtering with hydrodynamic trapping in a high-density array. Small cells follow streamlines that pass through trap apertures, intermediate-sized cells are admitted but retained by downstream constrictions, whereas larger cells occupy streamlines displaced from the channel wall and are hydrodynamically transported past the traps. As a result, only cells with diameters within the band-stop window are retained, while both smaller and larger cells pass. Using rigid microspheres, the device exhibits a canonical band-stop profile. Using cultured cell lines, capture efficiency peaks for CTC-like diameters and is suppressed for leukocyte-sized cells. Critically, the behaviour is preserved in undiluted, full haematocrit whole blood, where no leukocyte retention is observed and target-sized cancer cells are selectively enriched without fouling at capture efficiencies comparable to commercial systems. Trapped cells tolerate buffer exchange and on-chip drug exposure, where responses were concordant with matched off-chip culture. Cells are released on demand and expanded off-chip, confirming post-processing viability.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Krzeczkowski et al. (2026) studied this question.

synapsesocial.com/papers/69d895be6c1944d70ce06debhttps://doi.org/10.1039/d6lc00039h
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Estrogen Receptor α Mediates Doxorubicin Sensitivity in Breast Cancer Cells by Regulating E-Cadherin2021 · 38 citations
  2. 2Hydrodynamic filtration for on-chip particle concentration and classification utilizing microfluidics2005 · 504 citations
  3. 3The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells2008 · 8,774 citations
  4. 4Unusual Enhancement of Doxorubicin Activity on Co-Delivery with Polyhedral Oligomeric Silsesquioxane (POSS)2017 · 16 citations
  5. 5Diagnostic leukapheresis for CTC analysis in breast cancer patients: CTC frequency, clinical experiences and recommendations for standardized reporting2018 · 85 citations